收藏切换
Brief analysis of research and development in gene therapy for rare diseases
收藏切换
Yinghui YU1, Guiliang CHEN2, *
World Clinical Drug | 2023, 44(12) : 1339 - 1344
Less
收藏切换
World Clinical Drug | 2023, 44(12): 1339-1344
• Review •
Brief analysis of research and development in gene therapy for rare diseases
Full
Yinghui YU1, Guiliang CHEN2, *
Affiliations
  • 1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
  • 2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, China
Published: 2023-12-10 doi: 10.13683/j.wph.2023.12.017
Outline
收藏切换

In recent years, the research and development (R&D) of gene therapy has been increasingly highlighted, particularly in the field of rare diseases. As of August 4, 2023, a total of 10 rare disease gene therapy drugs have been approved for market in the world. There are 170 drugs in clinical and registration phases overseas, 46 drugs in clinical stages in China, and most of which are in early clinical phases. The indications covered by gene therapy drugs developed overseas are broader, while drugs developed locally in China have relatively concentrated indications. Biotech companies are the primary R&D enterprises of gene therapy for rare diseases, and many large MNC companies have entered this field through collaboration and acquisition. Currently, there are almost no large and medium-sized companies in China engaged in the R&D of gene therapy for rare diseases. With the development of innovative gene therapy-related technologies and support from relevant regulations, gene therapy will attract increasing attention from Chinese companies in the future. This article analyzed the gene therapy drugs that were currently approved and under development in the world for treating rare diseases to understand the R&D status of gene therapy for rare diseases drugs in China and abroad.

rare disease  /  gene therapy  /  research and development
俞颖慧, 陈桂良. 罕见病基因疗法研发现状简析. 世界临床药物, 2023 , 44 (12) : 1339 -1344 . DOI: 10.13683/j.wph.2023.12.017
Yinghui YU, Guiliang CHEN. Brief analysis of research and development in gene therapy for rare diseases[J]. World Clinical Drug, 2023 , 44 (12) : 1339 -1344 . DOI: 10.13683/j.wph.2023.12.017
Year 2023 volume 44 Issue 12
6
0
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.12.017
  • Receive Date:2023-08-21
  • Online Date:2026-11-18
  • Published:2023-12-10
Article Data
Affiliations
History
  • Received:2023-08-21
Affiliations
    1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
    2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.12.017
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT